Clinical Trial Update: Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating a combination of venetoclax, decitabine, and cedazuridine for relapsed or refractory acute myeloid leukemia and relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Biphenotypic Leukemia

Drugs mentioned

• Cedazuridine (Cedazuridine)
• Dacogen (decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING